We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
GLP‐1 agonists and hair loss: a call for further investigation.
- Authors
Desai, Deesha D.; Sikora, Michelle; Nohria, Ambika; Bordone, Lindsey; Caplan, Avrom S.; Shapiro, Jerry; Lo Sicco, Kristen I.
- Abstract
The widespread adoption of glucagon‐like peptide‐1 (GLP‐1) agonists in treating type 2 diabetes mellitus (T2DM) and obesity has sparked investigations into their impact on hair health, an area characterized by diverse conjectures. Some propose potential risks such as disrupted hair growth cycles or premature androgenetic alopecia (AGA), while others suggest benefits linked to improved insulin sensitivity and enhanced scalp blood circulation. However, despite these theoretical underpinnings, clinical evidence linking GLP‐1 agonists to hair loss remains sparse. The necessity for vigilant patient monitoring and collaborative efforts cannot be overstressed in comprehensively addressing any potential consequences of GLP‐1 agonist therapy on hair health as their use continues to expand.
- Subjects
TYPE 2 diabetes; HAIR growth; INSULIN sensitivity; BALDNESS; BLOOD circulation
- Publication
International Journal of Dermatology, 2024, Vol 63, Issue 9, p1128
- ISSN
0011-9059
- Publication type
Article
- DOI
10.1111/ijd.17246